• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

先天性心脏病产前检测的成本效益:一项系统文献综述

Cost-Effectiveness of the Prenatal Detection of Congenital Heart Diseases: A Systematic Literature Review.

作者信息

Londoño Trujillo Darío, Castro García Paula A, Rojas López Kristian K, Moreno-Medina Karen J, Dominguez Torres María T, Dennis Verano Rodolfo J, Sandoval Reyes Nestor F

机构信息

Fundación Santa Fe de Bogotá, Bogotá, Colombia.

Fundación Cardioinfantil-Instituto de Cardiología, Bogotá, Colombia.

出版信息

J Health Econ Outcomes Res. 2024 May 23;11(1):141-148. doi: 10.36469/001c.116147. eCollection 2024.

DOI:10.36469/001c.116147
PMID:38800495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11127739/
Abstract

Congenital heart disease is the most common congenital condition worldwide, with a prevalence of 80 cases per 10 000 live births. In addition to perinatal morbidity and mortality, it entails long-term consequences such as multiple surgeries, prolonged hospitalizations, lifelong cardiac follow-up, reduced quality of life, risk of heart failure, and premature mortality in adulthood. This significant health and economic burden on healthcare systems and families highlights the relevance of evaluating the cost-effectiveness of methods for early detection of this condition. To conduct a systematic literature review (SLR) to identify and analyze existing economic evaluations on prenatal detection of congenital heart diseases through ultrasound, focusing on the reported cost-effectiveness results and the methodological quality of the evaluated studies according to established criteria. An SLR of economic evaluations was conducted following PRISMA guidelines. A quantitative synthesis of key methodological components of each economic evaluation was performed. The incremental medical costs, effectiveness measures, and cost-effectiveness ratios reported in each study were compiled and compared. The methodological quality was assessed according to compliance with the 24 CHEERS criteria. We found 785 articles, of which only 7 met all inclusion criteria. Most were cost-effectiveness analyses, with the most common outcome being number of cases detected. Screening with only 4-chamber views interpreted by general practitioners or cardiologists were dominant strategies compared with screening with 4-chamber plus outflow views interpreted by a general practitioner. Fetal echocardiography was most effective but most expensive. Screening with 4-chamber and outflow view, followed by referral to a specialist, were recommended as the least expensive strategy per defect detected. On average, articles met 17 of the 24 CHEERS criteria. While recent cost-effectiveness analyses demonstrated improved methodological quality, there was a lack of homogeneity due to differences in comparators and population subgroups analyzed. Despite this heterogeneity, fetal ultrasonography screening was consistently identified as a cost-effective strategy, with its cost-effectiveness heavily influenced by the expertise of the interpreting physician. Most studies recommend implementing obstetric ultrasonography screening, without routine fetal echocardiography, for detecting congenital heart diseases.

摘要

先天性心脏病是全球最常见的先天性疾病,每10000例活产儿中患病率为80例。除围产期发病率和死亡率外,它还会带来长期后果,如多次手术、长期住院、终身心脏随访、生活质量下降、心力衰竭风险以及成年期过早死亡。这种对医疗系统和家庭造成的巨大健康和经济负担凸显了评估该疾病早期检测方法成本效益的重要性。进行系统文献综述(SLR),以识别和分析通过超声对先天性心脏病进行产前检测的现有经济评估,重点关注根据既定标准报告的成本效益结果和评估研究的方法学质量。按照PRISMA指南进行了经济评估的SLR。对每项经济评估的关键方法学组成部分进行了定量综合。汇总并比较了每项研究报告的增量医疗成本、效果指标和成本效益比。根据是否符合24条CHEERS标准评估方法学质量。我们发现了785篇文章,其中只有7篇符合所有纳入标准。大多数是成本效益分析,最常见的结果是检测到的病例数。与由全科医生解读四腔心切面加流出道切面进行筛查相比,仅由全科医生或心脏病专家解读四腔心切面进行筛查是主要策略。胎儿超声心动图最有效但最昂贵。推荐采用四腔心和流出道切面筛查,然后转诊至专科医生,作为每检测到一个缺陷成本最低的策略。平均而言,文章符合24条CHEERS标准中的17条。虽然最近的成本效益分析显示方法学质量有所提高,但由于所分析的比较对象和人群亚组存在差异,缺乏同质性。尽管存在这种异质性,胎儿超声筛查一直被认为是一种具有成本效益的策略,其成本效益受解读医生专业知识的严重影响。大多数研究建议实施产科超声筛查,而不进行常规胎儿超声心动图检查,以检测先天性心脏病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/11127739/79bb0f61cb54/jheor_2024_11_1_116147_223936.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/11127739/1add0b4e7fe5/jheor_2024_11_1_116147_223935.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/11127739/79bb0f61cb54/jheor_2024_11_1_116147_223936.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/11127739/1add0b4e7fe5/jheor_2024_11_1_116147_223935.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0cf/11127739/79bb0f61cb54/jheor_2024_11_1_116147_223936.jpg

相似文献

1
Cost-Effectiveness of the Prenatal Detection of Congenital Heart Diseases: A Systematic Literature Review.先天性心脏病产前检测的成本效益:一项系统文献综述
J Health Econ Outcomes Res. 2024 May 23;11(1):141-148. doi: 10.36469/001c.116147. eCollection 2024.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Cost-effectiveness of prenatal screening strategies for congenital heart disease.先天性心脏病产前筛查策略的成本效益
Ultrasound Obstet Gynecol. 2014 Jul;44(1):50-7. doi: 10.1002/uog.13287.
4
Detection of fetal cardiac anomalies: cost-effectiveness of increased number of cardiac views.检测胎儿心脏畸形:增加心脏切面数量的成本效益。
Ultrasound Obstet Gynecol. 2020 Jun;55(6):758-767. doi: 10.1002/uog.21977.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.行为修正干预对初级保健中无法用医学解释的症状:系统评价和经济评估。
Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460.
7
Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.体外受精受孕胎儿先天性心脏病产前筛查方法的成本效益分析。
Ultrasound Obstet Gynecol. 2021 Jun;57(6):979-986. doi: 10.1002/uog.22048. Epub 2021 May 5.
8
9
Evaluation of medical and health economic effectiveness of non-pharmacological secondary prevention of coronary heart disease.冠心病非药物二级预防的医疗卫生经济效果评估
GMS Health Technol Assess. 2009 Dec 14;5:Doc16. doi: 10.3205/hta000078.
10

本文引用的文献

1
Cost-effectiveness of prenatal screening methods for congenital heart defects in pregnancies conceived by in-vitro fertilization.体外受精受孕胎儿先天性心脏病产前筛查方法的成本效益分析。
Ultrasound Obstet Gynecol. 2021 Jun;57(6):979-986. doi: 10.1002/uog.22048. Epub 2021 May 5.
2
The Accuracy and Cost-Effectiveness of Selective Fetal Echocardiography for the Diagnosis of Congenital Heart Disease in Patients with Pregestational Diabetes Stratified by Hemoglobin A1c.糖化血红蛋白分层的孕前糖尿病患者先天性心脏病的选择性胎儿超声心动图诊断的准确性和成本效益。
Am J Perinatol. 2019 Oct;36(12):1216-1222. doi: 10.1055/s-0039-1685490. Epub 2019 Apr 16.
3
Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies.
全球先天性心脏病的出生患病率:1970-2017 年更新的 260 项研究系统评价和荟萃分析。
Int J Epidemiol. 2019 Apr 1;48(2):455-463. doi: 10.1093/ije/dyz009.
4
Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias: Versión en Español de la Lista de Comprobación CHEERS.卫生经济评估报告合并标准:CHEERS核对清单西班牙语版本。
Value Health Reg Issues. 2013 Dec;2(3):338-341. doi: 10.1016/j.vhri.2013.10.004. Epub 2013 Dec 12.
5
Micro-economic impact of congenital heart surgery: results of a prospective study from a limited-resource setting.先天性心脏手术的微观经济影响:来自资源有限地区的前瞻性研究结果
PLoS One. 2015 Jun 25;10(6):e0131348. doi: 10.1371/journal.pone.0131348. eCollection 2015.
6
Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association.胎儿心脏疾病的诊断与治疗:美国心脏协会科学声明
Circulation. 2014 May 27;129(21):2183-242. doi: 10.1161/01.cir.0000437597.44550.5d. Epub 2014 Apr 24.
7
Cost-effectiveness of prenatal screening strategies for congenital heart disease.先天性心脏病产前筛查策略的成本效益
Ultrasound Obstet Gynecol. 2014 Jul;44(1):50-7. doi: 10.1002/uog.13287.
8
The cost-effectiveness of prenatal detection for congenital heart disease using telemedicine screening.利用远程医疗筛查进行先天性心脏病产前检测的成本效益。
J Telemed Telecare. 2013 Jun;19(4):190-6. doi: 10.1258/jtt.2012.120418. Epub 2013 May 23.
9
Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.先天性心脏病的全球出生患病率:系统评价和荟萃分析。
J Am Coll Cardiol. 2011 Nov 15;58(21):2241-7. doi: 10.1016/j.jacc.2011.08.025.
10
[PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analyses].[PRISMA声明:一项改善系统评价和Meta分析报告质量的建议]
Med Clin (Barc). 2010 Oct 9;135(11):507-11. doi: 10.1016/j.medcli.2010.01.015. Epub 2010 Mar 5.